Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway | The Journal of Headache and Pain | Full Text

Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway | The Journal of Headache and Pain | Full Text

Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway

Migraine is a common and incapacitating condition, with severe impact on the quality of life (QoL) of the afflicted and their families, and negative economic consequences through decreased workforce participat...

Authors:Amanda Hansson-Hedblom, Isabelle Axelsson, Lena Jacobson, Joakim Tedroff and Fredrik Borgström

Citation:The Journal of Headache and Pain 2020 21:99

Content type:Research article

 

Published on: 12 August 2020

• ViewFull Text
 
• ViewPDF